• DataMeds AI entered an amended LOI on July 29 to acquire or exclusively license QOLPOM-related IP assets from EOS Technology Holdings and Scilex.
• Deal also contemplates buying control of Tollo Health via a membership-interest exchange with HealthBridge Advisors.
• Transaction remains subject to definitive agreements, due diligence, a fairness opinion, board and stockholder approvals, financing, Nasdaq requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036005), on August 04, 2026, and is solely responsible for the information contained therein.